Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2008 Nov 11;10545:17278-83. doi: 10.1073/pnas.0805820105.
Show Gene links
Show Anatomy links
Discovery of drug-like inhibitors of an essential RNA-editing ligase in Trypanosoma brucei.
Amaro RE
,
Schnaufer A
,
Interthal H
,
Hol W
,
Stuart KD
,
McCammon JA
.
???displayArticle.abstract???
Trypanosomatid RNA editing is a unique process and essential for these organisms. It therefore represents a drug target for a group of protozoa that includes the causative agents for African sleeping sickness and other devastating tropical and subtropical diseases. Here, we present drug-like inhibitors of a key enzyme in the editing machinery, RNA-editing ligase 1 (REL1). These inhibitors were identified through a strategy employing molecular dynamics to account for protein flexibility. A virtual screen of the REL1 crystal structure against the National Cancer Institute Diversity Set was performed by using AutoDock4. The top 30 compounds, predicted to interact with REL1's ATP-binding pocket, were further refined by using the relaxed complex scheme (RCS), which redocks the compounds to receptor structures extracted from an explicitly solvated molecular dynamics trajectory. The resulting reordering of the ligands and filtering based on drug-like properties resulted in an initial recommended set of 8 ligands, 2 of which exhibited micromolar activity against REL1. A subsequent hierarchical similarity search with the most active compound over the full National Cancer Institute database and RCS rescoring resulted in an additional set of 6 ligands, 2 of which were confirmed as REL1 inhibitors with IC(50) values of approximately 1 microM. Tests of the 3 most promising compounds against the most closely related bacteriophage T4 RNA ligase 2, as well as against human DNA ligase IIIbeta, indicated a considerable degree of selectivity for RNA ligases. These compounds are promising scaffolds for future drug design and discovery efforts against these important pathogens.
Amaro,
Functional and structural insights revealed by molecular dynamics simulations of an essential RNA editing ligase in Trypanosoma brucei.
2007, Pubmed
Amaro,
Functional and structural insights revealed by molecular dynamics simulations of an essential RNA editing ligase in Trypanosoma brucei.
2007,
Pubmed
Amaro,
An improved relaxed complex scheme for receptor flexibility in computer-aided drug design.
2008,
Pubmed
Barrett,
Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.
2007,
Pubmed
Brun,
Drug sensitivity of Chinese Trypanosoma evansi and Trypanosoma equiperdum isolates.
1994,
Pubmed
Carlson,
Protein flexibility and drug design: how to hit a moving target.
2002,
Pubmed
Carnes,
RNA editing in Trypanosoma brucei requires three different editosomes.
2008,
Pubmed
Cavasotto,
Protein flexibility in ligand docking and virtual screening to protein kinases.
2004,
Pubmed
Cheng,
Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase.
2008,
Pubmed
Claussen,
FlexE: efficient molecular docking considering protein structure variations.
2001,
Pubmed
Croft,
Chemotherapy of trypanosomiases and leishmaniasis.
2005,
Pubmed
Cross,
Trypanosomes at the gates.
2005,
Pubmed
Deng,
High resolution crystal structure of a key editosome enzyme from Trypanosoma brucei: RNA editing ligase 1.
2004,
Pubmed
Dolinsky,
PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations.
2004,
Pubmed
Hazuda,
A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase.
2004,
Pubmed
Ho,
Structure and mechanism of RNA ligase.
2004,
Pubmed
Huey,
A semiempirical free energy force field with charge-based desolvation.
2007,
Pubmed
Humphrey,
VMD: visual molecular dynamics.
1996,
Pubmed
Li,
Virtual screening of human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase against the NCI diversity set by use of AutoDock to identify novel nonfolate inhibitors.
2004,
Pubmed
Lin,
Computational drug design accommodating receptor flexibility: the relaxed complex scheme.
2002,
Pubmed
Lipinski,
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
2001,
Pubmed
McGovern,
A specific mechanism of nonspecific inhibition.
2003,
Pubmed
Miyashita,
Nonlinear elasticity, proteinquakes, and the energy landscapes of functional transitions in proteins.
2003,
Pubmed
Mäser,
Drug transport and drug resistance in African trypanosomes.
2003,
Pubmed
O'Donoghue,
On the evolution of structure in aminoacyl-tRNA synthetases.
2003,
Pubmed
Oprea,
Integrating virtual screening in lead discovery.
2004,
Pubmed
Pascal,
Human DNA ligase I completely encircles and partially unwinds nicked DNA.
2004,
Pubmed
Rusché,
The two RNA ligases of the Trypanosoma brucei RNA editing complex: cloning the essential band IV gene and identifying the band V gene.
2001,
Pubmed
Ryan,
Effect of detergent on "promiscuous" inhibitors.
2003,
Pubmed
Schames,
Discovery of a novel binding trench in HIV integrase.
2004,
Pubmed
Schnaufer,
An RNA ligase essential for RNA editing and survival of the bloodstream form of Trypanosoma brucei.
2001,
Pubmed
Schnaufer,
Natural and induced dyskinetoplastic trypanosomatids: how to live without mitochondrial DNA.
2002,
Pubmed
Schnaufer,
Separate insertion and deletion subcomplexes of the Trypanosoma brucei RNA editing complex.
2003,
Pubmed
Sherman,
Novel procedure for modeling ligand/receptor induced fit effects.
2006,
Pubmed
Shi,
Mining and visualizing large anticancer drug discovery databases.
2000,
Pubmed
Stuart,
Complex management: RNA editing in trypanosomes.
2005,
Pubmed
Tomkinson,
DNA ligases: structure, reaction mechanism, and function.
2006,
Pubmed
Voigt,
Comparison of the NCI open database with seven large chemical structural databases.
2001,
Pubmed
Wang,
Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomiasis.
1995,
Pubmed
Yin,
Structure-function analysis of T4 RNA ligase 2.
2003,
Pubmed
